Advisory Board

Dr. Andre Koltermann is a biotechnology entrepreneur, investor, and executive with more than 25 years of international leadership experience in life sciences, industrial biotechnology, and specialty chemicals. He co-founded Direvo Biotech AG, a pioneer in directed evolution technologies that was later acquired by Bayer Healthcare. In executive leadership positions at Süd-Chemie and Clariant, he led the development and commercialization of breakthrough biotechnology solutions. He has founded and co-founded several technology-driven companies, including Syntab Therapeutics and Efficient Robotics. Today, he advises and invests in early-stage ventures at the intersection of biotechnology and advanced technologies. At Syntab, he is the inventor of the company’s core technology platform and serves as Chairman of the Advisory Board.

Matthias Brede, B.B.A., born on September 20, 1960.

Studied mathematics and business administration in Göttingen.

Certified public accountant since 1992.

Partner at the firm am Nonnenstieg, PartGmbB, a tax consulting firm in Göttingen, since January 1, 1993.

Since January 3, 2025, he has been working as a freelance management consultant; he also serves on the boards of nonprofit foundations and associations. He is currently a member of several supervisory and advisory boards.

Studied history, law, and philosophy, earning a doctorate in legal history; has held executive positions in the field of real asset investments for over 25 years.

Managing Partner of Quarterdeck GmbH & Co. KG, a Hamburg-based investment firm.

Previously, among other roles, managing partner of an asset management firm, managing partner of a consulting firm for institutional investors, and board member of various asset management companies.